![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjQvMDIvMTIvbmV3X3lvcmtfc3RhdHVlX29mX2xpYmVydHktYWRvYmVfc3RvY2stZHdwLXJlc2l6ZWQyLmpwZw.moS0TEZkxIw.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
DWP | Adobe Stock
A New York lawmaker has introduced legislation to revamp the state’s medical cannabis program, in part by allowing out-of-state patients to shop at New York’s medical dispensaries.
Sen. Jeremy Cooney, D-Rochester, is sponsoring a bill that would not only provide reciprocity to nonresidents enrolled in other states’ medical cannabis programs, but would also allow patients to access prerolls, according to a Syracuse.com report.
Cooney told the news outlet that roughly a million out-of-state workers visit the state each day but cannot access medical cannabis in New York under current law.
His bill would remedy this, allowing certified medical cannabis patients from other states to purchase products from New York’s licensed medical dispensaries with documentation proving they are enrolled in another state’s medical cannabis program, Syracuse.com reported.
“New York is one of the most visited states in the country, from tourists to daily workers, so many non-New Yorkers utilize our state’s services,” Cooney told the news outlet. “Anyone who needs medical cannabis should be able to access it in New York if they’ve been approved in another state.”
New York’s medical cannabis operators—called registered organizations (ROs)—have been largely supportive of the legislation, claiming the proposal could help bolster the state’s medical cannabis program as patient enrollment gradually declines in the wake of New York launching commercial adult-use sales, Syracuse.com reported.
There were more than 151,000 certified medical cannabis patients in New York before lawmakers approved the state’s adult-use law in early 2021, according to the news outlet, but that number has since dropped to just over 120,400.
Cooney is also taking aim at medical cannabis policy reform with a separate bill this year that would repeal the 7% excise tax for medical cannabis products, Syracuse.com reported. He told the news outlet that bill is also meant to help retain patients in New York’s medical cannabis program.
“We can’t have a patient decide that it’s cheaper and easier to self-medicate using the retail market, or worse, the unregulated illicit market, when they should have easy access to high-quality, pharmaceutical-grade products,” Cooney said.
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial